Welcome to our dedicated page for BROADWAY FINANCIAL \DE\ SEC filings (Ticker: BYFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BROADWAY FINANCIAL \DE\'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BROADWAY FINANCIAL \DE\'s regulatory disclosures and financial reporting.
Broadway Financial Corporation announced that Nasdaq has confirmed the company is back in compliance with its listing requirements for timely reporting. On February 17, 2026, Nasdaq informed the company that it satisfied Listing Rule 5250(c)(1) after Broadway filed its Form 10-Q for the period ended September 30, 2025 on February 13, 2026. Nasdaq stated that the matter is now closed, meaning the prior reporting deficiency has been fully resolved and the company’s Nasdaq Capital Market listing is no longer at risk from this issue.
Broadway Financial Corporation reported a restated quarterly 10-Q showing a sharp swing to loss driven by a large non-cash goodwill write-down and higher credit costs. For the quarter ended September 30, 2025, the company posted a net loss attributable to the company of $23.9 million, versus net income of $0.5 million a year earlier, and a basic loss per common share of $2.86.
Results include a $25.9 million goodwill impairment, eliminating all recorded goodwill, and higher provision for credit losses, which lifted the allowance to $10.3 million. Management also restated prior periods after determining certain loan participations should be treated as secured borrowings rather than sales, modestly increasing both loan interest income and borrowing costs and revising cash flow presentation. Despite the loss, total assets were stable at about $1.34 billion, deposits rose to $849.2 million, and available-for-sale securities increased, while unrealized losses on securities narrowed, supporting positive other comprehensive income.
Broadway Financial Corporation disclosed that Nasdaq has notified the company it is not in compliance with Nasdaq Listing Rule 5250(c)(1) because its Form 10-Q for the quarter ended September 30, 2025 was not filed on time. The notice does not immediately affect the listing or trading of BYFC shares, and the company expects to regain compliance in the near future.
The delay stems from the company’s ongoing evaluation of its sold loan participation accounting under ASC 860 and the related impact on its consolidated financial statements. Broadway Financial previously received a Nasdaq extension to February 16, 2026 for filing its June 30, 2025 Form 10-Q, and any additional exception for all delinquent filings, including the Q3 Form 10-Q, is limited to that deadline. Nasdaq has given the company until December 8, 2025 to submit an updated compliance plan, and the company plans to provide this plan and file the Q3 Form 10-Q as promptly as reasonably practicable.
Broadway Financial Corp (BYFC) director reports stock sales. A single reporting person, serving as a director, sold a total of 10,000 shares of BYFC common stock through their broker between 10/02/2025 and 10/15/2025. The trades were executed in ten separate 1,000-share transactions at prices ranging from $7.0987 to $7.7 per share, described as part of ordinary course portfolio rebalancing. After these sales, the director beneficially owns 8,452 BYFC shares directly.
Broadway Financial Corporation reported that it has received an extension from Nasdaq until February 16, 2026 to file its delayed Quarterly Report on Form 10-Q for the quarter ended June 30, 2025. The company needs to file this report with the SEC in order to regain compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely financial reporting. The company states that it anticipates filing the Form 10-Q on or before the new deadline and that there is currently no immediate impact on its listing status on the Nasdaq Capital Market.
Broadway Financial (BYFC) reported an insider equity grant on Form 4. The company’s EVP, Chief Deposit Officer acquired 4,936 shares of common stock as restricted stock on 10/14/2025 at a reported price of $7.09. Following the transaction, the officer beneficially owned 4,936 shares, held directly.
The filing notes the award is a restricted stock grant with a 4-year vesting schedule under the Broadway Financial Corporation Amended and Restored 2018 Long-Term Incentive Plan effective April 16, 2023.
Broadway Financial (BYFC) filed a Form 3 reporting the initial beneficial ownership status of an executive serving as EVP, Chief Deposit Officer. The filing states that no securities are beneficially owned. The event date is October 14, 2025, and the form was submitted by one reporting person. This is a routine Section 16 disclosure indicating the officer currently reports no direct or indirect holdings.
Broadway Financial (BYFC) announced that its Audit Committee concluded goodwill is impaired under U.S. GAAP. The Company expects to record a non-cash $25.9 million goodwill impairment for the quarter ended September 30, 2025.
The write-down will reduce GAAP earnings for that period but does not reflect operating cash usage. Management stated it does not expect future cash expenditures related to this charge. Goodwill impairments occur when the carrying value of acquired businesses exceeds their estimated fair value.
Broadway Financial Corporation (NASDAQ: BYFC) announced a restatement of prior financial statements after its Audit Committee concluded certain loan participation agreements were recorded in error under ASC 860. As a result, the Company advised that its audited consolidated financial statements for fiscal years 2024 and 2023, and unaudited interim statements for the quarters ended March 31, 2024, June 30, 2024, September 30, 2024, and March 31, 2025 should no longer be relied upon.
The Company plans to file amendments to its 2024 Form 10-K and Q1 2025 Form 10-Q to restate the Affected Financials, impacting the balance sheet presentation, related interest income and interest expense, and the allowance for credit losses. Management identified a material weakness in internal control over financial reporting as of the original filing dates, which will be reported in the amendments. The Company discussed these matters with Baker Tilly US, LLP and Croe LLP.
Broadway Financial Corporation reported that Nasdaq has notified the company it is not in compliance with listing Rule 5250(c)(1) because its Form 10-Q for the quarter ended June 30, 2025 was not filed on time. The notice does not immediately affect the listing or trading of the company’s common stock on the Nasdaq Capital Market, and the company expects to regain compliance in the near future.
The delay stems from additional work needed to evaluate participation agreements under Accounting Standards Codification Topic 860 and to complete the related financial statement disclosures. Broadway Financial has 60 days from August 21, 2025 to submit a plan to regain compliance, and Nasdaq may allow up to February 16, 2026 to file the 10-Q if the plan is accepted. The company plans to file the Form 10-Q as promptly as reasonably practicable and has issued a press release describing the notice.